Reuters: Regulatory News: Bristol subpoenaed over foreign sales practices

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Bristol subpoenaed over foreign sales practices Apr 26th 2012, 17:59 April 26 | Thu Apr 26, 2012 1:59pm EDT April 26 (Reuters) - U.S. drugmaker Bristol-Myers Squibb Co said on Thursday that it received a subpoena from securities regulators regarding its sales and marketing practices in various foreign countries. Bristol-Myers, in a filing, said it received the subpoena from the U.S. Securities and Exchange Commission (SEC) last month in connection with an investigation under the Foreign Corrupt Practices Act (FCPA). The company said it was cooperating with the government in its investigation. It declined to divulge what countries or products were involved in the probe or to give any details beyond the brief statement in the filing. Foreign practices among major pharmaceutical companies have come under increasing scrutiny by government regulators as the drugmakers look to expand business into emerging markets. A Reuters examination of U.S. SEC filings by the world's top 10 drug companies has found that eight of them recently warned of potential costs related to charges of corruption in overseas markets. The FCPA has been in the spotlight since a recent New York Times report said senior Wal-Mart Stores Inc executives stymied an investigation into alleged bribery by its Mexican affiliate, which involved suspect payments of $24 million. In October, cosmetics company Avon Products Inc disclosed that it was being probed by the federal government for potential FCPA violations.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions